Trials / Active Not Recruiting
Active Not RecruitingNCT01892397
Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to find out what effects, good or bad, the Optune device has on the patient and meningioma. This study is being done because currently there are no proven effective medical treatments for a progressive meningioma that has failed surgery and/or radiation. The study uses an experimental device called Optune. Optune is "experimental" because it has not been approved by the U.S. Food and Drug Administration (FDA) for this type of tumor, although it has been approved for a different type of brain tumor.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Optune (NovoTTF-100A) |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2013-07-04
- Last updated
- 2025-07-02
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01892397. Inclusion in this directory is not an endorsement.